Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
2021
Joanna Howard
Kevin H.M. Kuo
Abdulafeez Oluyadi
Hui Shao
Susan Morris
Ahmar U Zaidi
Eduard J. van Beers
Swee Lay Thien
Keywords:
Gastroenterology
Disease
Medicine
Placebo-controlled study
double blind
Phase (matter)
Internal medicine
in patient
Cell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]